Corticosterone modifies muscarinic receptor immunoreactivity in rat hippocampus

Neurosci Lett. 1999 Jun 11;268(1):41-4. doi: 10.1016/s0304-3940(99)00377-8.

Abstract

In the present study we report the effect of corticosterone in the regulation of hippocampal muscarinic acetylcholine receptor immunoreactivity (mAChR-ir) expression in rats. Adrenalectomy (ADX) or a single injection of a mineralocorticoid antagonist RU-28318 (1.0 mg/100 g body weight (b.w.)) in adrenally intact rats 24 h prior to sacrifice revealed an increased mAChR-ir in hippocampal CA1 and CA3 areas. Corticosterone replacement (100 microg/100 g b.w.) prevented the increase in mAChR-ir of ADX animals. However, glucocorticoid receptor antagonist (RU38486) treatment in adrenally intact rats failed to affect the mAChR immunolabeling. These results point to a modulation of muscarinic receptors by corticosterone that is predominantly mediated by the mineralocorticoid receptor.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylcholine / analysis
  • Acetylcholine / biosynthesis*
  • Adrenalectomy
  • Animals
  • Corticosterone / pharmacology*
  • Hippocampus / chemistry
  • Hippocampus / drug effects*
  • Hippocampus / metabolism
  • Immunohistochemistry
  • Male
  • Mifepristone / pharmacology
  • Rats
  • Rats, Wistar
  • Receptors, Muscarinic / metabolism*
  • Spironolactone / analogs & derivatives
  • Spironolactone / pharmacology

Substances

  • Receptors, Muscarinic
  • Spironolactone
  • Mifepristone
  • RU 28318
  • Acetylcholine
  • Corticosterone